COWAN ELVIA (SVP, Finance & CAO) sold 7.5% of their position (2.50K shares) of VAXCYTE, INC. on the open market
Open‑market sale worth $146.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/11/2026ACC: 0001960048-26-000004
Officer· SVP, Finance & CAO
Since Feb 2026
-3K
Net shares
Net seller
$175.8K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
2.50K acquired · 5.50K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−495.00
Price / share
$59.32
Trade value
$29.36K
% of position
1.6%
3/9/2026
31.36K→30.87K
Common Stock
Direct
Shares
+2.50K
Price / share
$25.92
Trade value
$64.80K
% of position
8.1%
3/11/2026
30.87K→33.37K
Common Stock
Direct
Shares
−2.50K
Price / share
$58.59
Trade value
$146.48K
% of position
7.5%
3/11/2026
33.37K→30.87K
Total
Net shares
−495.00
Net value
-$111.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/9/2026 | F · Tax Withholding | −495.00 | $59.32 | $29.36K | 1.6% | 31.36K | 30.87K |
| Common Stock Direct | 3/11/2026 | M · Option Exercise | +2.50K | $25.92 | $64.80K | 8.1% | 30.87K | 33.37K |
| Common Stock Direct | 3/11/2026 | S · Sale | −2.50K | $58.59 | $146.48K | 7.5% | 33.37K | 30.87K |
| Total | −495.00 | -$111.05K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
2.50K shares
Shares
−2.50K
Strike price
25.92
Held after
96.07K
Exercisable
—
3/11/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock2.50K shares | 3/11/2026 | M · Option Exercise | −2.50K | 25.92 | — | 96.07K |